Serum Eosinophilic Cationic Protein as a Useful Noninvasive Marker of Eosinophilic Gastrointestinal Disease in Children
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Recently, the prevalence of eosinophilic gastrointestinal disease (EGID) has shown an increasing trend worldwide. As the diagnosis of EGID requires invasive endoscopy with biopsy, noninvasive markers for detecting EGID in suspected patients, particularly children, are urgently needed. Therefore, this study aimed to evaluate the diagnostic accuracy of serum eosinophil cationic protein (ECP) beyond peripheral eosinophil counts in pediatric patients with EGID. Methods: Overall, 156 children diagnosed with EGID were enrolled and 150 children with functional abdominal pain disorder (FAPD) were recruited as controls. All participants underwent endoscopic biopsy in each segment of the gastrointestinal (GI) tract and serum ECP measurement, as well as peripheral eosinophil percent and absolute eosinophil count. Results: Comparing EGID (n=156) with FAPD (n=150) patients, serum ECP levels were significantly higher in pediatric patients with EGID than in those with FAPD (25.8±28.6 μg/L vs. 19.5±21.0 μg/L, p=0.007), while there was no significant difference in peripheral eosinophil percent and absolute eosinophil counts between the two groups. Serum ECP levels were correlated with peripheral eosinophil percent (r=0.593, p<0.001) and the absolute eosinophil count (r=0.660, p<0.001). The optimal cutoff value of serum ECP for pediatric EGID was 10.5 μg/mL, with a sensitivity of 69.9% and a specificity of 43.4% with an area under the receiver operating characteristic curve of 0.562. Conclusion: The combination of serum ECP levels and peripheral eosinophil counts, when employed with appropriated thresholds, could serve as a valuable noninvasive biomarker to distinguish between EGID and FAPD in pediatric patients manifesting GI symptoms.
Abstract
Purpose: Recently, the prevalence of eosinophilic gastrointestinal disease (EGID) has shown an increasing trend worldwide. As the diagnosis of EGID requires invasive endoscopy with biopsy, noninvasive markers for detecting EGID in suspected patients, particularly children, are urgently needed. Therefore, this study aimed to evaluate the diagnostic accuracy of serum eosinophil cationic protein (ECP) beyond peripheral eosinophil counts in pediatric patients with EGID. Methods: Overall, 156 children diagnosed with EGID were enrolled and 150 children with functional abdominal pain disorder (FAPD) were recruited as controls. All participants underwent endoscopic biopsy in each segment of the gastrointestinal (GI) tract and serum ECP measurement, as well as peripheral eosinophil percent and absolute eosinophil count. Results: Comparing EGID (n=156) with FAPD (n=150) patients, serum ECP levels were significantly higher in pediatric patients with EGID than in those with FAPD (25.8±28.6 μg/L vs. 19.5±21.0 μg/L, p=0.007), while there was no significant difference in peripheral eosinophil percent and absolute eosinophil counts between the two groups. Serum ECP levels were correlated with peripheral eosinophil percent (r=0.593, p<0.001) and the absolute eosinophil count (r=0.660, p<0.001). The optimal cutoff value of serum ECP for pediatric EGID was 10.5 μg/mL, with a sensitivity of 69.9% and a specificity of 43.4% with an area under the receiver operating characteristic curve of 0.562. Conclusion: The combination of serum ECP levels and peripheral eosinophil counts, when employed with appropriated thresholds, could serve as a valuable noninvasive biomarker to distinguish between EGID and FAPD in pediatric patients manifesting GI symptoms.
참고문헌 (25)
- Dellon ES, "International consensus recommendations for eosinophilic gastrointestinal disease nomenclature", Clin Gastroenterol Hepatol, 20, pp.2474~2484 (2022)
- Alhmaoud T, "Eosinophilic gastroenteritis : an underdiagnosed condition", Dig Dis Sci, 61, pp.2585~2592 (2016)
- Uppal V, "Eosinophilic gastroenteritis and colitis : a comprehensive review", Clin Rev Allergy Immunol, 50, pp.175~188 (2016)
- Spergel JM, "Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States", J Pediatr Gastroenterol Nutr, 52, pp.300~306 (2011)
- Jensen ET, "Prevalence of eosinophilic gastritis, gastroenteritis, and colitis : estimates from a national administrative database", J Pediatr Gastroenterol Nutr, 62, pp.36~42 (2016)
- Steinbach EC, "Eosinophilic esophagitis and the eosinophilic gastrointestinal disease : approach to diagnosis and management", J Allergy Clin Immunol Pract, 6, pp.1483~1495 (2018)
- Licari A, "Eosinophilic gastrointestinal diseases in children : a practical review", Curr Pediatr Rev, 16, pp.106~114 (2019)
- Talley NJ, "Eosinophilic gastroenteritis : a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues", Gut, 31, pp.54~58 (1990)
- Rothenberg ME, "Eosinophilic gastrointestinal disorder(EGID)", J Allergy Clin Immunol, 113, pp.11~28 (2004)
- Yoo IH, "Fecal calprotectin as a useful non-invasive screening marker for eosinophilic gastrointestinal disorder in Korean children", J Korean Med Sci, 35, pp.e120~ (2020)
- Berthet S, "Eosinophilic esophagitis. clinical presentation, allergology and treatment: a series of 22 children", Arch Pediatr, 18, pp.7~14 (2011)
- Gurkan OE, "Primary eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis in children", J Pediatr Gastroenterol Nutr, 72, pp.294~299 (2021)
- Hyams JS, "Functional disorder : children and adolescents", Gastroenterology, 150, pp.1456~1468 (2016)
- Lee EH, "Quantitative analysis of distribution of the gastrointestinal tract eosinophils in childhood functional abdominal pain disorders", J Neurogastroenterol Motil, 24, pp.614~626 (2018)
- Singh T, "Characterizing inflammatory cell asthma associated phenotypes in dental health workers using cytokine profiling", Front Allergy, 2, pp.747591~ (2021)
- Travers J, "Eosinophils in mucosal immune responses", Mucosal Immunol, 8, pp.464~475 (2015)
- Lee EH, "Analysis of gastric and duodenal eosinophils in children with abdominal pain related functional gastrointestinal disorders according to Rome III criteria", J Neurogastroenterol Motil, 22, pp.459~469 (2016)
- Abassa KK, "Diagnosis of eosinophilic gastroenteritis is easily missed", World J Gastroenterol, 23, pp.3556~3564 (2017)
- Brenner EJ, "Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis", Clin Res Hepatol Gastroenterol, 45, pp.101746~ (2021)
- Desreumaux P, "Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis", Gastroenterology, 110, pp.768~774 (1996)
- Koh GC, "Eosinophil cationic protein: is it useful in asthma? a systematic review", Respir Med, 101, pp.696~705 (2007)
- Beppu T, "Eosinophil and eosinophil cationic protein in allergic rhinitis", Acta Otolaryngol Suppl, 511, pp.221~223 (1994)
- Czech W, "Serum eosinophil cationic protein(ECP)is a sensitive measure for disease activity in atopic dermatitis", Br J Dermatol, 126, pp.351~355 (1992)
- Witek JD, "Assessing eosinophilic cationic protein as a biomarker for monitoring patients with eosinophilic esophagitis treated with specific exclusion diets", World Allergy Organ J, 10, pp.12~ (2017)
- Wechsler JB, "Noninvasive biomarkers identify eosinophilic esophagitis : a prospective longitudinal study in children", Allergy, 76, pp.3755~3765 (2021)